Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...

In their paper, the researchers write that the rationale for developing a classification of diabetic nephropathy that applies to both T1DM and T2DM is that “substantial overlap exists between ...

The following is a summary of “Mitochondrial Metabolism Gene ECH1 Was Identified as a Novel Biomarker for Diabetic ...

The global burden of chronic kidney disease associated with diabetes has been and is expected to continue increasing.

People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications ...

IgA nephropathy (IgAN) is characterized by the deposition of IgA1-containing immune complexes in the glomerular mesangium. The pathogenesis follows a 4-hit cascade: ...

There is evidence that injury to the glomerular podocyte is central to the pathogenesis of diabetic nephropathy and that clinical treatments should be directed toward maintaining podocyte viability.

Disturbances in LSS to induce turbulent flow around arterial branch points are heavily implicated in the pathogenesis of atherosclerosis ... the protective effect of INFβ in animal models of diabetic ...

Six-month open-label study showed clinically meaningful improvements in kidney function and disease in patients with Type 2 diabetic nephropathy. 71% achieved a >30% reduction in UP/Cr ...